Know Cancer

or
forgot password


N/A
18 Years
N/A
Open (Enrolling)
Both
Actinic Keratosis

Thank you

Trial Information


Inclusion Criteria:



1. Subjects who are 18 and older

2. Subjects who have at least 3 actinic keratoses on each side of the forehead

3. Subjects who signed an IRB approved informed consent

Exclusion Criteria:

1. Subjects who smoke

2. Subjects who have a photosensitizing condition such as lupus, porphyria, or similar
condition.

3. Subjects who received a diagnosis of skin cancer on the face in past year

4. Subjects who received field treatment for actinic keratoses to the face in the past
60 days

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Outcome Measure:

complete response rate

Outcome Time Frame:

one month after treatment

Safety Issue:

No

Authority:

United States: Institutional Review Board

Study ID:

2821 50-5

NCT ID:

NCT01812837

Start Date:

July 2012

Completion Date:

Related Keywords:

  • Actinic Keratosis
  • actinic keratosis
  • microneedles
  • photodynamic therapy
  • levulan
  • Aminolevulinic acid
  • Keratosis
  • Keratosis, Actinic

Name

Location

UC Davis, DermatologySacramento, California  95864